Clinical trial
Topical IL-1-Ra for Treatment of Corneal Neovascularization
NCT00915590 is registered in ClinicalTrials.gov with Reza Dana, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical IL-1-Ra for Treatment of Corneal Neovascularization
- Lead sponsor
- Reza Dana, MD
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- April 30, 2009
- Completion date
- March 31, 2011
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.